User menu

Concentration-controlled everolimus versus MMF in De Novo heart transplant patients: Incidence of CMV infection at 12 months post-transplant in a randomized trial

Bibliographic reference Dengler, T. ; Vigano, M. ; Magelli, C. ; Guillemain, R. ; Varnous, S. ; et. al. Concentration-controlled everolimus versus MMF in De Novo heart transplant patients: Incidence of CMV infection at 12 months post-transplant in a randomized trial.28th Annual Meeting of the International-Society-for-Heart-and-Lung-Transplantation (Boston (Ma), Apr 09-12, 2008). In: The Journal of Heart and Lung Transplantation, Vol. 27, no. 2, p. S65-S66 (2008)
Permanent URL http://hdl.handle.net/2078.1/59475